New Data on Long-Term Use of FIRMAGON (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology
CONTACT: Christy Maginn of Burson-Marsteller, +1-646-280-5210, christy.maginn@bm.com, or Ashley Owens DiLeo of Burson-Marsteller, +1-202-530-4560, ashley.dileo@bm.com, or Keith Piper of Ferring Pharmaceuticals, +1-888-FERRING, Keith.piper@ferring.com
Posted: September 2011